Countries deploying growing number of nuclear weapons, international monitors warn

9,745 nuclear warheads were assessed as quickly available last year, up 141 from 2024, with 4,012 (40%) deployed on missiles/submarines/bomber bases (an increase of 108); the total combined stockpile was 12,187 at the start of the year (down 144 from early 2025). Analysts warn this signals the end of nuclear reductions, a renewed arms race amid the lapse of New START, and materially higher risks of rapid escalation and accidental use — a significant geopolitical risk that could broaden market risk premia.

Analysis

This dynamic shifts marginal government spending from soft infrastructure toward high-TRL defense and strategic systems over the next 12–36 months, meaning revenue growth will concentrate in long-lead prime contractors and specialty subsystem suppliers rather than broad industrials. Procurement is multi-year and backloaded: new programs create visible book-to-bill improvements for primes and discrete winners in RF, guidance, and composite manufacturing, but the cash flow realization lags award dates by quarters, creating staging opportunities to enter ahead of reported bookings.

Second-order supply-chain winners include domestic GaN/SiC RF component suppliers, precision optics and space sensor vendors, and US shipyards with classified workscopes — these vendors gain pricing power from export controls and onshoring because substitution is slow and capital-intensive. Conversely, large diversified industrials and commercial aerospace OEMs face margin pressure as defense work replaces more stable commercial backlogs; they’ll also absorb higher warranty and program-risk exposure from accelerated schedules.

Catalysts and tail risks are asymmetric: near-term (days–weeks) market moves will be driven by headline escalation or successful diplomatic breaks; medium-term (3–12 months) drivers are contract awards, budget cycles and export-control rulings; multi-year outcomes depend on sustained political consensus and fiscal capacity. A renewed arms-control agreement or sharp fiscal tightening would reverse investor exposure quickly, while supply-chain fractures or sanctions creating single-source dependence would amplify vendor-level upside.

The consensus—positioning long across the whole ‘defense basket’—misses dispersion: a concentrated small-cap supplier with unique RF/space IP can double from a 1–2 year backlog swing, while several megaprimes remain vulnerable to program delays, protest risk and EU/UK political pushback. Active selection and tail-hedging are essential.

Key Decisions for Investors

• Buy Lockheed Martin (LMT) shares — entry on any 3–6% pullback; target +18–25% in 12 months driven by new program awards and FCF expansion; position size 3–5% portfolio. Stop-loss at -8% to limit exposure to political/budget reversals.
• Buy Qorvo (QRVO) or equivalent GaN-focused RF supplier — accumulate over 6–12 weeks; catalyst: defense RF orders and export-control substitution. Target +25–35% in 12 months; risk: 12% downside if commercial demand softens. Consider Jan 2027 LEAPS calls for leveraged exposure with defined premium risk.
• Buy Huntington Ingalls Industries (HII) — thesis: increased naval procurement and classified shipbuilding work create multi-year revenue visibility. Target +20–30% over 12–24 months; allocate 2–4% portfolio. Hedge with a 25–30% notional put on the position to protect against program cancellation risk.
• Purchase tactical tail-hedge: buy 3–6 month SPY 8–12% OTM puts (or VIX call spread) allocating 0.5–1% of portfolio to protect against rapid escalation and equity flight-to-safety. R/R: small premium for outsized payoff in geopolitical shock scenarios.